Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Ampio Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 18,750 50,000 50,000
Cost of Goods Sold (COGS) incl. D&A - 0 42,551 - -
COGS excluding D&A - 0 0 - -
Depreciation & Amortization Expense - 0 42,551 62,396 137,680
Depreciation - 0 8,475 16,940 72,169
Amortization of Intangibles - 0 34,076 45,456 65,511
Gross Income - 0 (23,801) - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 6.7M 11.11M 11.81M 23.94M
Research & Development - 1.97M 6.65M 7.49M 18.29M
Other SG&A - 4.73M 4.46M 4.31M 5.65M
Other Operating Expense - 0 0 0 0
Unusual Expense 0 1.33M 7.14M (205,768) 516,840
EBIT after Unusual Expense 0 (1.33M) (7.14M) 205,768 (516,840)
Non Operating Income/Expense 4,179 0 0 0 0
Non-Operating Interest Income 0 815 6,684 21,943 12,287
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 4,179 19,545 8,358 0 -
Gross Interest Expense 4,179 19,545 8,358 0 -
Interest Capitalized 0 0 0 0 0
Pretax Income (26,051) (8.05M) (18.28M) (11.59M) (24.53M)
Income Tax 0 0 82,500 0 0
Income Tax - Current Domestic 0 0 - 0 -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (26,051) (8.05M) (18.36M) (11.59M) (24.53M)
Minority Interest Expense 0 0 0 0 (519,868)
Net Income (26,051) (8.05M) (18.36M) (11.59M) (24.01M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (26,051) (8.05M) (18.36M) (11.59M) (24.01M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (26,051) (8.05M) (18.36M) (11.59M) (24.01M)
EPS (Basic) (0.03) (0.49) (0.71) (0.34) (0.63)
Basic Shares Outstanding 929,718 16.29M 26.01M 33.98M 38.29M
EPS (Diluted) (0.03) (0.49) (0.71) (0.34) (0.63)
Diluted Shares Outstanding 929,718 16.29M 26.01M 33.98M 38.29M
EBITDA - (6.7M) (11.09M) (11.76M) (23.89M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.